Manufactures and sells nutritional supplements. Offers NeuBecalm'd to reduce the effects of stress. Now — the numbers.
This is an established company with proven profits.
The gap is $133K. In times of high interest rates, a gap like that can squeeze a company.
The market pays 0.5× for every dollar of annual profit — cheap, which is either an opportunity or a warning.
No analyst target is on record for this company.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are going backwards, not just slowing.
An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Our checks did not surface a specific strength to highlight here.
The stock sits at $0.0001. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
This stock swings about 5.7 times as much as the market average. Big rallies — and big drops — can both happen fast.
Over the last 2 years, sales fell about 16% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the growth trend, earnings execution, the revenue breakdown.